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Abstract
 BACKGROUND—Emerging evidence indicates that the association between depression and 
subsequent cardiovascular events is largely mediated by health behaviors. However, it is unclear 
whether depression is the cause or the consequence of poor health behaviors.
 PURPOSE—To examine prospective, bidirectional relationships of depressive symptoms with 
behavioral and lifestyle factors among patients with coronary heart disease.
 METHODS—Depressive symptoms and lifestyle behaviors (physical activity, medication 
adherence, body mass index, waist-to-hip ratio, sleep quality, and smoking status) were assessed at 
baseline and 5 years later among a prospective cohort of 667 patients with stable coronary heart 
disease.
 RESULTS—Greater depressive symptoms at baseline predicted poorer lifestyle behaviors 5 
years later (less physical activity, lower medication adherence, higher body mass index, higher 
waist-to-hip ratio, worse sleep quality, and smoking). After adjustment for demographics, cardiac 
disease severity, comorbidity, and baseline lifestyle behaviors, depressive symptom severity 
remained predictive of subsequent worsening of physical activity (beta = −0.08; 95% CI= −0.16, 
−0.01; p = 0.03), medication adherence (beta = −0.16; 95% CI= −0.24, −0.08; p < 0.001), and 
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sleep quality (beta = −0.19; 95% CI = −0.27, −0.11; p < 0.001). Baseline lifestyle behaviors also 
predicted 5-year change in depressive symptoms, although the associations were attenuated after 
adjustment for baseline depressive symptoms and covariates.
 CONCLUSIONS—Among patients with coronary heart disease, depressive symptoms were 
linked to a range of lifestyle risk factors and predicted further declines in physical activity, 
medication adherence, and sleep quality.
Keywords
depression; coronary heart disease; health behaviors; physical activity; medication adherence; 
sleep quality
 Introduction
Depression is an independent risk factor for the development of incident cardiovascular 
disease (CVD) in healthy populations and adverse outcomes among patients with existing 
CVD (1–3). Recent evidence indicates that poor health behaviors, particularly physical 
inactivity, may be the primary mechanisms whereby depression leads to an increased risk of 
subsequent cardiovascular events (4–8). However, the direction of association between 
depression and health behaviors, or modifiable lifestyle factors in general, is unclear.
Previous studies have tested unidirectional relationships between depression and lifestyle 
behaviors and have provided support for both directions of association. A substantial body 
of literature has shown that lifestyle behaviors predict subsequent depression. For example, 
smoking and obesity have been associated with a greater risk of clinically-significant 
depressive symptoms 4 to 17 years later (9–11). Multiple longitudinal studies have linked 
physical activity to a reduced likelihood of subsequent depression (12), whereas sleep 
disturbances increase the risk of incident depression (13). Furthermore, randomized trials 
have demonstrated that exercise is as effective as sertraline for alleviating depressive 
symptoms (14–16).
Conversely, accumulating evidence suggests that depression is a risk factor for the 
development of poor health behaviors. A review of 11 longitudinal studies reported robust 
associations between depression and subsequent physical inactivity (17). Depressive 
symptoms have been linked to a cluster of behavioral risk factors among patients post-
myocardial infarction, including lower adherence to recommendations for diet, exercise, 
medication regimens, stress reduction, and socializing (18). Other studies indicate that 
depressive symptoms or a history of major depression elevates the risks of high body mass 
index (BMI), abdominal obesity, and regular smoking (19–21). Although these studies 
collectively suggest that bidirectional relationships likely exist between depression and 
lifestyle behaviors, few studies have formally tested both directions of the association.
We have previously shown in the Heart and Soul Study—a prospective cohort study of 1024 
patients with stable coronary heart disease (CHD)—that depressive symptoms were 
associated with a higher rate of subsequent cardiovascular events, and this association was 
largely explained by poor health behaviors (4). However, to our knowledge, whether 
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depressive symptoms are the cause or the result of poor lifestyle behaviors has not been 
examined in patients with CHD. We therefore sought to evaluate the longitudinal, 
bidirectional relationships of depressive symptoms with behavioral and lifestyle factors 
(physical activity, medication adherence, body mass index, waist-to-hip ratio [WHR], sleep 
quality, and smoking) across 5 years in the Heart and Soul Study.
 Methods
 Participants
The Heart and Soul Study is a prospective cohort study designed to determine how 
depression and other psychological factors influence cardiovascular outcomes in patients 
with stable CHD (4). Patients with documented stable CHD were recruited from the San 
Francisco Veterans Affairs Medical Center, the Veterans Affairs Palo Alto Health Care 
System, 1 university medical center (University of California, San Francisco), and 9 public 
health clinics in the Community Health Network of San Francisco. To be eligible, patients 
needed to have at least one of the following: a history of myocardial infarction, angiographic 
evidence of at least 50% stenosis in one or more coronary vessels, evidence of exercise-
induced ischemia via treadmill or nuclear testing, a history of coronary revascularization, or 
coronary artery disease previously noted by an internist or cardiologist. Patients were 
excluded from the study if they considered themselves incapable of walking 1 block, if they 
experienced acute coronary syndrome in the prior 6 months, or if they planned to move out 
of the local area within 3 years.
A total of 1024 participants were enrolled between September 11, 2000 and December 20, 
2002. Five years later, 829 participants were alive and 667 (80% of survivors) returned for a 
5-year examination. Thus, our final sample was comprised of 667 participants with follow-
up data. Compared to participants who did not survive or who dropped out of the study, 
those with follow-up data tended to be younger, had higher income, were less likely to 
smoke, and reported less depressive symptoms and more physical activity at baseline. 
Participants at follow-up were also relatively less likely to have had a stroke, heart failure, or 
diabetes mellitus. We controlled for these demographic and clinical differences in the 
analyses. There were no differences in medication adherence, BMI, WHR, or sleep quality 
based on survival/dropout status. All participants provided written informed consent, and 
procedures were approved by the appropriate institutional review boards.
 Measures
Depressive symptoms and lifestyle behaviors were assessed at baseline and again 5 years 
later.
 Depressive symptoms—We evaluated depressive symptoms using the 9-item Patient 
Health Questionnaire (PHQ-9) (22), which assessed the frequency of depressive symptoms 
corresponding to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, 
criteria for depression (23). Participants reported how often they experienced each of nine 
depressive symptoms over the past two weeks using the following answer choices: 0 (not at 
all), 1 (several days), 2 (more than half the days), and 3 (nearly every day). Scores were 
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summed, for a total ranging between 0 and 27. The PHQ-9 has been shown to be a reliable 
and valid measure for assessing the severity of depressive symptoms in patients with CHD 
(22,24).
 Lifestyle behaviors
 Physical activity: Participants were asked, “Which of the following statements best 
describes how physically active you have been during the last month, that is, done activities 
such as 15–20 minutes of brisk walking, swimming, general conditioning, or recreational 
sports?” Answers were scored as follows: 0 = not at all active, 1 = a little active, 2 = fairly 
active, 3 = quite active, 4 = very active, and 5 = extremely active. Point values ranged from 0 
to 5, with higher scores indicating greater physical activity. This one-item measure of 
physical activity was predictive of subsequent inflammation, insulin resistance, 
cardiovascular events, and mortality in this cohort (4,25). Self-reported physical activity has 
been shown to be a valid and reliable assessment of physical activity (26–28).
 Medication adherence: Medication adherence was measured by the question, “Overall, 
in the past month, how often did you take your medications as the doctor prescribed?” 
Answers were scored as follows: 0 = less than half of the time (<50%), 1 = about half of the 
time (50%), 2 = most of the time (75%), 3 = nearly all of the time (90%), and 4 = all of the 
time (100%). Scores ranged from 0 to 4, with higher scores indicating greater medication 
adherence. Previous research in the Heart and Soul Study has linked this measure of 
medication nonadherence to concurrent depression (29) and prospective risk of 
cardiovascular events (30). Self-reported medication adherence is moderately-to-highly 
concordant with objective measures of adherence (e.g., monitoring using electronic pill 
caps) (31).
 BMI and central adiposity: Diet was not measured in the Heart and Soul Study. BMI 
and WHR were used instead as indirect indicators of diet and physical activity. Participant 
height and weight were measured by study personnel and used to calculate BMI (kg/m2). In 
addition, we examined WHR due to research suggesting that WHR and other indices of 
central adiposity may be better than BMI for predicting CVD risk and events (32,33). WHR 
was calculated from measures of waist circumference and hip circumference. Because of sex 
differences in WHR, all analyses involving WHR were adjusted for sex.
 Sleep quality: Participants responded to the following item from the Pittsburgh Sleep 
Quality Index (PSQI), “During the last month, how would you rate your sleep quality 
overall?” Possible response choices were: Very bad, fairly bad, good, fairly good, or very 
good. Responses were coded such that higher scores referred to better sleep quality. This 
single item (which comprises the entire subjective sleep quality component of the full PSQI 
scale) has demonstrated high test-retest reliability, convergent and discriminant validity, and 
the highest correlation with the PSQI global score than the other subscales (34,35).
 Smoking: We determined participants’ smoking status based on their responses to a 
single question: “Do you currently smoke cigarettes?” Self-reported smoking has been 
shown to be comparable to biochemical assessments of smoking (36).
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 Covariates—Demographics and medical history were obtained by self-report 
questionnaire at baseline. To assess baseline cardiac disease severity, resting 
echocardiography and an exercise treadmill test were performed. Left ventricular ejection 
fraction was calculated as (end diastolic volume – end systolic volume)/end diastolic 
volume. Participants were categorized as having diastolic dysfunction if their mitral inflow 
ratio of peak early-to-late diastolic filling velocity was greater than 0.75 and if their velocity 
time integral in the pulmonary vein was greater during diastole than during systole (37). 
Inducible ischemia was defined as the presence of new echocardiographic wall motion 
abnormalities at peak exercise during treadmill testing that were not present at rest (38).
 Data analysis
First, we analyzed the bivariate associations between baseline participant characteristics 
(demographics, comorbid conditions, and cardiac disease severity) and baseline depressive 
symptoms, using the established cutoff of PHQ-9 score ≥ 10 to indicate the presence of 
clinically significant depressive symptoms (22). We used t-tests for continuous variables and 
chi-squared tests for categorical variables. Participant characteristics that were associated 
with depressive symptoms at p < 0.10 were subsequently included as covariates in the 
multivariate analyses.
Next, we used multivariate linear regression to test baseline depressive symptoms as a 
predictor of change in lifestyle behaviors (i.e., depressive symptoms predicting Year 5 
lifestyle behaviors, while adjusting for baseline lifestyle behaviors). Depressive symptoms 
and lifestyle behaviors were analyzed as continuous variables. Due to differences in 
measurement scales across the lifestyle behaviors, standardized β coefficients were used to 
represent standard deviation change in lifestyle behaviors. A series of three models were run 
for each lifestyle factor. Model 1 was unadjusted, except analyses with WHR were adjusted 
for sex. Model 2 was adjusted for age, sex, White race, education, and income. Model 3 
included additional covariates for left ventricular ejection fraction, comorbid conditions 
(heart failure, stroke, and diabetes mellitus), and the corresponding baseline lifestyle 
behavior. Furthermore, based on associations between participant characteristics and specific 
lifestyle behaviors (see Supplementary Table 1), we also adjusted for history of 
revascularization in analyses of physical activity and medication adherence, as well as 
adjusting for hypertension in analyses of BMI and WHR. Because smoking status was 
assessed as a dichotomous variable, analyses involving smoking status were conducted using 
logistic regression.
Finally, to address the possible bidirectional nature of the relationships between depressive 
symptoms and lifestyle behaviors, we used multivariate linear regression to evaluate the 
relationship between each lifestyle behavior at baseline and subsequent worsening of 
depressive symptoms over 5 years. Unstandardized B coefficients were used to represent 
mean change in PHQ-9 score. Analyses were conducted using SAS version 9.4 (SAS 
Institute Inc., Cary, NC).
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 Results
 Baseline participant characteristics
Of the 667 participants with stable CHD included in our analyses, 116 (17%) had depressive 
symptoms (indicated by a PHQ-9 score ≥ 10). The prevalence of depression in this sample 
was comparable to that of patients hospitalized with acute myocardial infarction (15–20%) 
(39,40). Less is known about the prevalence of depression in outpatients with CHD. In the 
National Health Interview Survey of 30,801 adults, the 12-month prevalence of major 
depression was 9.3% among patients with coronary heart disease and 4.8% in individuals 
without chronic medical conditions (41).
Participants with depressive symptoms were less likely to have graduated high school and 
were more likely to be younger, female, and to have an income below $20,000/year (Table 
1). Those with depressive symptoms were also more likely to have congestive heart failure 
and lower left ventricular ejection fraction. Depressive symptoms were not associated with 
race, other comorbid conditions (hypertension, myocardial infarction, stroke, 
revascularization, or diabetes mellitus), or other measures of cardiac disease severity (the 
presence of diastolic dysfunction or inducible ischemia).
 Descriptive statistics and correlations
Descriptive statistics for change in depressive symptoms and lifestyle behaviors are provided 
in Supplementary Table 2. In bivariate correlations (Table 2), baseline depressive symptoms 
were associated with poorer lifestyle behaviors at Year 5: less physical activity, lower 
medication adherence, poorer sleep quality, higher WHR (partialed for sex) and BMI, and 
smoking. Based on Cohen’s guidelines for interpreting Pearson r effect sizes (42), the 
longitudinal correlations between baseline depressive symptoms and Year 5 lifestyle 
behaviors were primarily small-to-medium in size (i.e., r = 0.10 – 0.30), whereas there was a 
medium-to-large effect of −0.39 for baseline depressive symptoms and subsequent sleep 
quality.
 Baseline depressive symptoms and 5-year change in lifestyle behaviors
Baseline depressive symptoms predicted subsequent poor lifestyle behaviors in regression 
analyses (Figure 1). After 5 years of follow-up (Table 3), each standard deviation (SD) or 
5.3-point increase in baseline depressive symptoms was associated with declines in physical 
activity, worsening medication adherence, increases in BMI and sex-adjusted WHR, and 
poorer sleep quality. Baseline depressive symptoms also predicted 43% greater odds of 
being a smoker at follow-up. After full adjustment for demographics, ejection fraction, 
comorbid conditions, and baseline lifestyle behaviors, each SD increase in baseline 
depressive symptoms was associated with 8% of a SD decrease in physical activity 5 years 
later (p = 0.03), 16% of a SD decrease in medication adherence (p < 0.001), and 19% of a 
SD decrease in sleep quality (p < 0.001). The associations of baseline depressive symptoms 
with 5-year WHR and smoking were reduced to non-significance after accounting for 
demographics, whereas the association with subsequent BMI was explained by comorbid 
conditions.
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 Baseline lifestyle behaviors and 5-year change in depressive symptoms
In unadjusted models, poorer baseline lifestyle behaviors (relatively less physical activity, 
lower medication adherence, higher BMI, poorer sleep quality, and smoking) predicted 
worsening of depressive symptoms across 5 years (Table 4). Higher baseline WHR was also 
marginally predictive of 5-year increases in depressive symptoms (p = 0.09). However, 
baseline lifestyle behaviors were no longer associated with subsequent changes in depressive 
symptoms after adjusting for baseline depressive symptoms, demographics, ejection 
fraction, and comorbid conditions.
 Discussion
Previous research has linked depression with modifiable lifestyle behaviors that increase risk 
of adverse cardiovascular outcomes, but the extent to which depression is the cause or the 
consequence of lifestyle behaviors is unclear. In the current study, we evaluated the 
bidirectional associations between depressive symptoms and multiple lifestyle behaviors 
across five years among 667 patients with stable CHD. The findings support both directions 
of association, although evidence was stronger for depressive symptoms as a predictor of 
subsequent health behavior change. Specifically, depressive symptoms were linked to less 
physical activity, lower medication adherence, higher BMI and WHR, poorer sleep quality, 
and smoking five years later. After accounting for baseline lifestyle behaviors, 
demographics, cardiac disease severity, and comorbid conditions, depressive symptoms 
remained independently predictive of 5-year decline in physical activity, medication 
adherence, and sleep quality. In contrast, the associations between baseline lifestyle 
behaviors and 5-year change in depressive symptoms were not significant after accounting 
for baseline depressive symptoms.
Based on prior studies, cardiac patients with depression are known to be relatively less likely 
to engage in cardiovascular prevention behaviors, including physical activity (17), 
medication adherence (18,43), smoking cessation (18,44,45), and cardiac rehabilitation (45–
47). Our study extends this literature by demonstrating that baseline depressive symptoms 
were not only associated with the presence of poor lifestyle behaviors 5 years later, but also 
predicted declines in physical activity, medication adherence, and sleep quality. The effect 
sizes were mostly small-to-medium in magnitude, yet modest effects can have substantial 
implications when considered at the population level or as risks accrue across a lifetime. 
Given the importance of psychosocial factors for determining CVD risk and mortality 
(3,48), these findings suggest that depressive symptoms may serve as critical targets in 
efforts to improve health behaviors among patients with CHD.
We found that depressive symptoms predicted some behaviors but not others. Smoking was 
strongly determined by younger age and indicators of socioeconomic disadvantage, 
including being an ethnic minority and having low income. WHR is known to vary 
systematically by age, sex, and ethnicity (49); thus, it was not surprising that depressive 
symptoms were no longer predictive of WHR after accounting for demographic factors. As 
expected, BMI was confounded with hypertension and diabetes; adjusting for comorbid 
conditions eliminated the association between baseline depressive symptoms and subsequent 
BMI. Our analyses were conservative and perhaps underestimated the links between 
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depressive symptoms and anthropometric measures. For example, it is possible that 
depressive symptoms prospectively influence obesity, thereby increasing risk for diabetes 
and hypertension (50).
Prospective studies have shown that obesity, sleep difficulties, and physical activity predict 
the likelihood of developing major depression (9,10,12,13,51,52). We therefore expected 
baseline lifestyle behaviors to be significantly predictive of subsequent changes in 
depressive symptoms, but these associations were explained by baseline depressive 
symptoms. Our findings may have differed from other prospective studies because many 
prior studies focused on predicting incident major depression and thus excluded participants 
with depression at baseline (12,13,52). In contrast, our study examined changes in 
depressive symptom severity. Consistent with our findings, a meta-analysis showed that 
obesity was more predictive of subsequent major depression than of increases in depressive 
symptoms (52). In addition, a 10-year study of adults with depression found that physical 
activity and depressive symptoms were concurrently associated on each of four waves of 
assessment, but physical activity did not predict future changes in depressive symptoms (53). 
Furthermore, our sample was composed of middle-aged and older adults with chronic CHD, 
rather than younger, healthier participants as in prior research (9,10,54). The effects of 
lifestyle behaviors on depressive symptoms may differ in sicker patients with chronic 
medical conditions than in non-clinical populations (53).
Although depressive symptoms and lifestyle behaviors are commonly thought to have 
reciprocal influences, the current study is only one of several (and perhaps the first with 
cardiac patients) that have formally tested bidirectional relationships. Previous investigations 
of bidirectional associations have produced mixed results: bidirectional associations have 
linked depressive symptoms to high BMI (55), smoking (54), and insomnia (56), but others 
have found no long-term relationships between depression and physical activity (53) or only 
a unidirectional association leading from obesity to subsequent depression (51). The mixed 
findings may be due to differences in lifestyle behaviors, samples (e. g., community-based 
older adults, young adults, and persons with major depression), follow-up periods spanning 
from 1 to 10 years, and methodology (e.g., some studies did not adjust for baseline values or 
physical health).
A number of potential physiological and psychosocial pathways have been proposed to 
explain the links between depressive symptoms and lifestyle risk factors. There is 
compelling evidence supporting the role of inflammatory responses in the pathophysiology 
of depression (57). Physical inactivity, inadequate sleep, and other unhealthy behaviors can 
lead to elevated inflammation (25) and thus contribute to the development and exacerbation 
of depressive symptoms. On the other hand, specific symptoms of depression—including 
loss of interest, hopelessness, fatigue, and trouble remembering—may reduce one’s 
motivation or ability to maintain physical activity and medication regimens. Patients with 
elevated depressive symptoms may also have low cardiac self-efficacy (i.e., less confidence 
in their ability to manage their health), thereby resulting in poor health behaviors and worse 
clinical outcomes (58). In addition, depression is confounded with other psychosocial 
factors, such as low social support, that increase the risk of poor health behaviors. Future 
studies should seek to better understand how depression leads to worse lifestyle behaviors, 
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and vice versa, particularly for chronic conditions in which optimal lifestyle behaviors are 
critical for disease management.
Evidence from other populations suggests that depression treatment can improve health 
behaviors, such as antiretroviral medication adherence among persons living with HIV/
AIDS (59). It is unclear, however, whether treatment of depressive symptoms will help 
promote a healthy lifestyle in patients with cardiovascular disease. Randomized clinical 
trials of antidepressant treatment and psychotherapy for cardiac patients with depression 
have shown only modest effects on depressive symptoms but no improvements in 
cardiovascular outcomes (60–62). By contrast, exercise interventions have been effective for 
ameliorating depressive symptoms, improving cardiovascular biomarkers, and reducing the 
risk of hospitalizations and mortality (14,63,64). Although our observational study did not 
find an association between baseline lifestyle behaviors and subsequent changes in 
depressive symptoms, programs targeting comprehensive lifestyle changes—particularly 
cardiac rehabilitation—are known to confer benefits for both mental well-being (65) and 
physical health (65–67).
Several limitations should be considered when interpreting the findings of this study. First, 
causal conclusions cannot be drawn due to the observational nature of the study. We were 
careful in adjusting for potential confounding variables, but it remains possible that other 
factors were responsible for the prospective associations between depressive symptoms and 
lifestyle behaviors. Second, this study lacked direct measures of diet and sleep hygiene. 
BMI, WHR, and sleep quality—although generally seen as modifiable lifestyle factors—are 
not health behaviors per se but the results of health behaviors. Third, with the exception of 
BMI and WHR, lifestyle behaviors were measured by self-report using single items. The 
items for physical activity and medication adherence predicted future cardiovascular events 
in this cohort (4,30), yet the findings would be strengthened if more comprehensive, 
psychometrically-validated scales were used. Furthermore, self-report measures are 
susceptible to recall or response biases (68). To the extent that depression influences self-
report of health behaviors, the discordance between subjective and objective measures could 
result in over- or under-estimated effects. For example, a meta-analysis found that the 
association between depression and medication nonadherence was weaker when adherence 
was measured using pharmacy refill records compared to self-report and electronic cap 
measures (69). It is unclear whether self-reported adherence is overestimated or whether it 
captures behaviors (e.g., incorrectly-timed doses or not ingesting medications) that cannot be 
determined from objective measures. Further work is needed to compare the links between 
depression and health behaviors using different types of self-report and objective measures. 
Finally, although this sample was racially diverse and had a range of diagnoses, women and 
more severe cases of CHD were underrepresented. Only those participants who survived and 
were healthy enough to return for the 5-year exam were included in this analysis. Thus, the 
findings may not generalize to less healthy patients or to other populations.
In summary, psychological and behavioral factors have long been implicated in the 
development and prognosis of CHD. This study demonstrates that depressive symptoms 
predict long-term worsening of health behaviors that are critical for disease management. 
Likewise, poor health behaviors and high BMI are prospectively linked to increases in 
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depressive symptoms, although the associations are relatively less robust. These 
bidirectional findings are especially important given the growing evidence that lifestyle 
behaviors may be largely responsible for the adverse cardiovascular events and mortality 
associated with depression. Considering the intricate link between depressive symptoms and 
lifestyle behaviors, future work should evaluate whether depression treatment leads to 
downstream changes in health behaviors and improvements in cardiovascular outcomes.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Poor lifestyle behaviors at Year 5 by baseline depressive symptoms (N = 667)
For illustrative purposes, baseline depressive symptoms were dichotomized by Patient 
Health Questionnaire-9 score (< 10 for no depression versus ≥ 10 for depression). In 
unadjusted logistic regression analyses, severity of depressive symptoms at baseline was 
associated with poor health behaviors 5 years later: being “not at all active” or “a little 
active” (4); taking medications as prescribed 75% or less of the time (29); obesity as defined 
by body mass index ≥ 30 kg/m2 (49), sleep quality rated as “fairly bad” or “very bad” (70), 
and smoking (all p-values ≤ 0.005). Adjusting for sex, baseline depressive symptoms also 
predicted high waist-to-hip ratio at follow-up, based on the World Health Organization’s 
recommended cutoff of 0.9 for men (49).
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Table 1
Baseline characteristics of 667 participants with stable coronary heart disease, by depressive symptomsa
Participant characteristic
Depressive
Symptoms
(N = 116)
No Depressive
Symptoms
(N = 551) P-value
Demographics
  Age, mean (SD) years 62.6 (11.0) 66.8 (9.9) <0.001
  Male sex, No. (%) 87 (75.0) 462 (83.9) 0.023
  White, No. (%) 68 (58.6) 330 (59.9) 0.80
  High school graduate, No. (%) 94 (81.0) 490 (89.3) 0.014
  Income < $20,000/year, No. (%) 78 (67.2) 230 (42.0) <0.001
Comorbid conditions, No. (%)
  Hypertension 82 (70.7) 382 (69.3) 0.77
  Myocardial infarction 63 (54.8) 283 (51.5) 0.52
  Stroke 14 (12.2) 70 (12.7) 0.87
  Revascularization 65 (56.5) 338 (61.3) 0.34
  Congestive heart failure 27 (23.3) 71 (13.0) 0.004
  Diabetes mellitus 32 (27.6) 125 (22.7) 0.26
Cardiac disease severity
  Left ventricular ejection fraction, mean (SD) % 60.6 (9.4) 62.9 (8.7) 0.014
  Diastolic dysfunction, No. (%) 10 (10.1) 50 (9.9) 0.95
  Inducible ischemia, No. (%) 19 (18.5) 100 (19.3) 0.85
a
Patient Health Questionnaire score ≥ 10 versus < 10
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Table 4
Association between baseline lifestyle behaviors and 5-year change in depressive symptoms
Mean Increase in Depressive Symptoms
Predictora Bb (95% CI) P-value
Less Physical Activity (Per 1-Unit Decrease)
  Model 1 0.742 (0.509, 0.976) <0.001
  Model 2 0.592 (0.362, 0.822) <0.001
  Model 3 0.129 (−0.068, 0.325) 0.20
Lower Medication Adherence (Per 1-Unit Decrease)
  Model 1 0.814 (0.284, 1.343) 0.003
  Model 2 0.659 (0.145, 1.174) 0.01
  Model 3 0.206 (−0.218, 0.630) 0.34
Higher Body Mass Index (Per 1-Unit Increase)
  Model 1 0.130 (0.054, 0.206) <0.001
  Model 2 0.102 (0.026, 0.178) 0.009
  Model 3 0.037 (−0.025, 0.099) 0.25
Higher Waist-to-Hip Ratio (Per 1-Unit Increase)
  Model 1 4.921 (−0.713, 10.556) 0.09
  Model 2 4.846 (−0.628, 10.321) 0.08
  Model 3 1.074 (−3.518, 5.666) 0.65
Poorer Sleep Quality (Per 1-Unit Decrease)
  Model 1 1.474 (1.126, 1.821) <0.001
  Model 2 1.348 (1.012, 1.684) <0.001
  Model 3 0.201 (−0.113, 0.515) 0.21
Smoker (vs. Non-Smoker)
  Model 1 2.306 (1.240, 3.371) <0.001
  Model 2 1.292 (0.201, 2.384) 0.02
  Model 3 0.788 (−0.104, 1.680) 0.08
aModel 1 was unadjusted, except the analysis for waist-to-hip ratio was adjusted for sex. Model 2 adjusted for demographics: Age, sex, White race, 
high school graduate, and annual household income < $20,000. Model 3 adjusted for demographics, left ventricular ejection fraction, heart failure, 
stroke, diabetes mellitus, and baseline depressive symptoms as a continuous variable. Analyses for physical activity and medication adherence also 
adjusted for history of revascularization, whereas analyses for BMI and WHR included additional adjustment for hypertension.
b
The unstandardized B coefficient refers to the mean change in depressive symptoms (Patient Health Questionnaire-9 score) across the 5-year 
period, for each 1-unit difference in baseline lifestyle behaviors or for smokers vs. non-smokers.
Ann Behav Med. Author manuscript; available in PMC 2017 August 01.
